FUSION ANTIBODIES PLC ORD GBP0.04 revenue for the last year amounted to 1.14 M GBP, the most of which — 1.14 M GBP — came from its highest performing source at the moment, Recombinant Proteins and Antibodies, the year earlier bringing 2.90 M GBP. The greatest contribution to the revenue figure was made by North America and Rest of World — last year it brought FUSION ANTIBODIES PLC ORD GBP0.04 846.00 k GBP.